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Abstract
Many micronutrients or cofactors derived from micronutrients are highly reactive, hence their role in catalysis of reactions by
enzymes. The concentration of cofactors has to be kept low to avoid unwanted reactions while allowing them to bind to the
(apo)enzymes that need them. A new disorder causing B6-responsive epilepsy (proline synthetase cotranscribed bacterial
homologue deficiency) is probably due to the absence of an important intracellular pyridoxal phosphate chaperone. The
availability of some micronutrients varies by orders of magnitude in different geographical areas. Selenium is both essential
and toxic, and during evolution, different populations have had to adapt to this differing availability. An “inborn error of
metabolism (IEM)” in a low selenium area of China may be a selective advantage in a high selenium area and vice versa; the
concept of nutrigenomics is an important one for micronutrients. The gut flora may make an important contribution to vitamin
synthesis. This is difficult to study, but experiments can be undertaken with the nematode, Caenorhabditis elegans (with or without
an IEM) and a single clone of Escherichia coli (with or without an IEM) as food and gut flora. This model shows that the gut
microbiome can have profound influences on the folate cycle and associated vitamins. Our innate immune system makes use of
the micronutrient requirements of pathogens and can deprive a pathogen of essential micronutrient(s) or expose it to toxic levels.
It is not surprising, therefore, that some mutations affecting the way the host handles micronutrients can confer an advantage in
resistance to infection and this may have acted as a selective advantage during evolution. This will be discussed by reference to the
relationship of inborn errors to resistance to malaria. Conversely, other inborn errors of micronutrient metabolism are likely to
make it more difficult for the host to use nutritional immunity to fight infection; this probably accounts for the list of infections that
are more serious in patients with hereditary haemochromatosis.
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Introduction
The inborn errors affecting micronutrient metabolism are a
very important group as they can often be treated effectively,
for example, by increasing the intake of the micronutrient or
speeding its elimination. There is accumulating evidence that
micronutrient availability has led to evolutionary adaptations
making man better able to survive as he has moved to areas
with a lower or higher micronutrient availability. Furthermore,
natural selection has favored genetic variants that improve our
ability to use micronutrients in the fight against infection, var-
iants that either restrict the availability of a micronutrient to a
pathogen or subject it to toxic levels—“nutritional immunity.”
When considering the availability of micronutrients, it is
important to remember that the gut flora can synthesize vita-
mins and so a dietary deficiency may be compensated in the
holobiome. This review will focus on inborn errors and poly-
morphisms affecting micronutrient metabolism in the holo-
biome starting with a recently described inborn error that
illustrates the need to carefully regulate the concentration of
a highly reactive micronutrient in our cells.
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The Reactivity of Pyridoxal Phosphate and
Proline Synthetase Cotranscribed Bacterial
Homologue Deficiency
Pyridoxal 5’-phosphate (PLP) is the active cofactor derived
from all forms of vitamin B6 in the diet. It has a reactive
aldehyde group, with the reactivity further enhanced by the
phosphate group that prevents hydration of the aldehyde group
(as occurs in pyridoxal) and by the aromatic ring that provides
an electron sink. The aldehyde groups can react with amino
and sulphydryl groups as well as the activated carbon atoms in
D1-pyrroline-5-carboxylate (P5C) and D1-piperideine-6-
carboxylate (P6C), compounds that accumulate in hyperproli-
naemia type II and ALDH7A1 deficiency, respectively.1-3 To
prevent inappropriate reactions, it is estimated that the concen-
tration of the free PLP is kept in the low micromolar range.
Abundant proteins that can bind to PLP and keep the free PLP
concentration low include albumin in plasma, hemoglobin in
red cells, and glycogen phosphorylase in muscle. However, the
cell must be able to deliver PLP to the apoenzymes that need it.
We have found evidence to indicate that there is an intracellular
protein that helps fulfill this role—proline synthetase
cotranscribed bacterial homologue (PROSC) now renamed as
pyridoxal phosphate binding protein.4 Proline synthetase
cotranscribed bacterial homologue was known to be a ubiqui-
tously expressed protein that could bind PLP without any
alteration in its quaternary structure and, while its structure was
similar to that of alanine racemase, it had no apparent enzyme
activity when tested with a range of amino acids. We had some
discussions with Andrew Hanson as to whether it might prevent
reaction of PLP with P6C and P5C. Then, at the 2012 SSIEM
Meeting in Birmingham, Isa Holme and Niklas Darin told us of
their studies on a family in which 2 siblings and a cousin had
B6-responsive epilepsy and in whom mapping studies and
exome analysis had shown a homozygous missense mutation
in PROSC. We then sequenced PROSC in a cohort of 29 indi-
viduals with pyridoxine-responsive seizures of unknown cause
and identified a further 4 patients with biallelic PROSC
mutations.
The clinical features of the 7 patients thus identified4
included features similar to those seen in other B6 disorders
such as pyridoxamine phosphate oxidase (PNPO) deficiency—
abnormal intrauterine movements (3/7), fetal distress (4/7),
neonatal seizures (7/7) with burst suppression on electroence-
phalography (5/7), and a clear response to B6 (7/7). In addition,
patients tended to have a birth head circumference below the
9th centile (4/7). Other features included systemic disease—
lactic acidosis (4/7), anemia (2/7), and gastrointestinal dys-
function (3/7). Seizure control was somewhat better with PLP
than pyridoxine (4/4), but most patients required an additional
anticonvulsant for full seizure control (5/6). On follow-up,
microcephaly was increasingly evident and most patients had
a degree of developmental delay. Early computed tomography
and magnetic resonance imaging (MRI) scans showed broad
gyri and shallow sulci indicating an underdeveloped brain.
Some patients had periventricular germinolytic cysts and
others deep white matter edema and hemorrhages. Scans in
childhood showed reduced myelination.
When we looked at the pretreatment cerebrospinal fluid
(CSF) samples from the patients with PROSC mutations, we
found low PLP levels and evidence of impaired activity of
PLP-dependent enzymes such as aromatic amino acid decar-
boxylase (AADC)—elevated CSF concentrations of 3-ortho-
methyldopa, L-dopa, and/or 5-hydroxytryptophan—and urinary
organic acid analysis showed raised vanillactate, also consis-
tent with reduced AADC activity. These results confirmed the
hypothesis that delivery of PLP to apo-AADC in the brain was
impaired.
When PROSC-deficient fibroblasts were cultured in
medium containing the usual amounts of fetal calf serum (a
source of PLP) and supplementary pyridoxine, the cell content
of PLP measured as nmol PLP per gram of cell protein was
higher in the children with PROSC deficiency than in controls
and a heterozygote. When the cell extract was fractionated into
components with molecular weight below and above 3 kDa, the
PLP content for PROSC-deficient patients was found to be
increased in both fractions, suggesting that there was accumu-
lation of PLP bound to both proteins and metabolites. This was
compatible with the hypothesis that PROSC is an intracellular
PLP binding protein preventing inappropriate reactions with
both small and large molecules.
We then did some expression studies with Valerie de Crecy-
Lagard, Laurence Prunetti, and Basma El Yacoubi from the
University of Florida in Gainesville. They had shown that when
Escherichia coli with a deletion of the PROSC homologue
(DyggS) were cultured in a dish containing a pyridoxine-
soaked disc, there was a ring of growth inhibition around the
disc. Transfection with wild-type human PROSC abolished
pyridoxine sensitivity. Human mutants affecting highly con-
served regions of PROSC did not abolish E coli pyridoxine
sensitivity. A missense mutant affecting an area not fully con-
served across species did abolish E coli pyridoxine sensitivity.
These studies provided further evidence that PROSC prevents
toxic reactions of vitamin B6.
Plecko and colleagues have since shown that mutations in
PROSC are also a cause of vitamin B6-dependent epilepsy in
their cohort.5 Onset of seizures in their patients was <10 days,
and seizures were promptly controlled by pyridoxine in all
patients, except one whose seizures had already been con-
trolled by phenobarbitone. In contrast to our patients, all their
patients were normocephalic with normal MRI scans and three
out of four had normal IQ when assessed at 12.5, 15.5, and
30 years.
Geographical Variation in Micronutrient
Availability
Deficiency of a micronutrient is a major world health problem.
At least 2 billion people in the world are deficient in key
vitamins and/or minerals, the commonest deficiencies being
vitamin A, iodine, iron, and zinc.6 In some areas of the world,
there is also a risk of specific micronutrient toxicity. A good
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example of this is selenium; availability of this micronutrient
varies by orders of magnitude between different geographical
areas. Even within China, there are areas where people are at
risk of deficiency and areas where there is a greater at risk of
toxicity. Deficiency can give rise to an impaired immune
response, infertility, cognitive decline, increased mortality, and
specific forms of heart disease (Keshan) and bone disease
(Kashin-Beck). Excess selenium, on the other hand, can cause
nausea and vomiting, nail discoloration, brittleness, and loss,
hair loss, fatigue, irritability, and a foul garlic breath odor. As
man migrated out of Africa 60 000 to 100 000 years ago, he
encountered both high and low selenium environments.
White and coworkers looked at variants in selenium-related
genes in individuals living in high- and low-selenium areas.7
They found that there was a glutathione peroxidase allele with
increased catalytic efficiency of selenium that was more com-
mon in individuals living in low-selenium areas than in indi-
viduals from higher selenium areas. They found many other
variants in genes regulating selenium and in selenoproteins in
out-of-Africa migrants compared to ancestral African genes.
This leads us to the conclusion that what is an inborn error of
metabolism (IEM) in one geographical area might be a selec-
tive advantage in another!
The Gut Flora as a Source of Micronutrients;
The Microbiome
The gut flora may be very important in micronutrient metabo-
lism; bacteria are able to synthesize many vitamins. Unfortu-
nately, the interaction between the host and the gut flora is
complicated and difficult to study. We were fortunate to be
invited to participate in a series of experiments on an elegant
model system devised by Filipe Gomes Cabreiro and col-
leagues working in another part of UCL.8
For the nematode Caenorhabditis elegans, bacteria consti-
tute both a food and a source of a gut flora. It is relatively
straightforward to study the effect of the interaction between
a worm with or without a knockout of an enzyme involved in
micronutrient metabolism and fed a single E coli strain with or
without a knockout of an enzyme involved in micronutrient
metabolism. We can’t go into detail for all combinations tested
but will give 1 example. The worms were treated with the
anticancer drug, 5-fluorouracil (5FU), at varying concentra-
tions and the 5FU toxicity was measured by the fraction of the
nematode’s eggs that hatched at that concentration of 5FU. The
main way in which 5FU prevents cellular replication is by
inhibition of thymidylate synthesis leading to a deficient con-
version of deoxyuridine monophosphate to deoxythymidine
monophosphate for DNA synthesis. Reduced folates stabilize
the 5FdUMP-TS complex that formed and enhance 5FU toxi-
city. When the worm was fed bacteria with a defect in the de
novo pathway for PLP synthesis, the pdxJ strain, the worm’s
PLP level was virtually undetectable, and the toxicity of 5FU
was markedly reduced compared to that in worms fed wild-type
bacteria. When the worm was fed supplementary pyridoxal, its
PLP level could be restored and the normal high toxicity of
5FU was also restored. This confirms previous work that indi-
cates that 5FU toxicity is closely linked to the activity of the
folate cycle and hence to PLP levels. 5-Fluorouracil toxicity is
reduced by PLP deficiency. The important point here is that
bacterial micronutrient metabolism can have a profound effect
on host metabolism, including the metabolism of xenobiotics.
Conversely, there is increasing evidence that host metabo-
lism can affect the species of bacteria present in the mamma-
lian gut and their metabolic pathways. Vitamin D, acting on the
vitamin D receptor, affects the production of antimicrobial
peptides by the mouse including the cathelicidin antimicrobial
peptides, b-defensins, and the autophagy regulator ATG16L1.9
When the vitamin D receptor is knocked out in the mouse, there
are changes both in the species of bacteria found in the large
bowel and in the expression of their genes. The pathways upre-
gulated in the bacteria in the caecum of the mouse include those
affecting other micronutrients including riboflavin, retinol, and
others.9
Inborn Errors and Carrier States That May
Increase Resistance to Malaria
We have mentioned the fact that inborn errors of micronutrient
metabolism might increase or decrease an individual’s ability
to use nutritional immunity to overcome an infection. It is
believed that the ability to survive infection with the malarial
parasite has been an important selective advantage in evolu-
tion. We have listed a few common inborn errors (and carrier
states) affecting micronutrient metabolism that may confer
resistance to malaria. These include the following.
Genetic Variants Leading to Low Free Pyridoxal
Phosphate in Erythrocytes
Americans of Afro-Caribbean origin have a high incidence of a
polymorphism in the erythroid-specific promoter of pyridoxal
kinase.10 This leads to low activity of pyridoxal kinase and this
is thought to confer resistance to malaria. Sickle hemoglobin
binds PLP more avidly than normal b-hemoglobin.11 This may
reduce the availability of free PLP to the parasites in the red
cells. Children with sickle cell trait have protection against
malaria morbidity and mortality.12 The R116Q variant in
PNPO markedly reduces the synthesis of PLP from pyridoxine
phosphate in red cells.13 We have suggested that the relatively
high frequency of this mutation may be explained by resistance
to malaria.14 In the Ferrara Province of Italy, where malaria
was endemic in the 12th century, there is a high incidence of
individuals with a low activity of both PNPO and glutathione
reductase and this cannot be explained by dietary riboflavin
intake: the postulated reason for the high incidence is that
reduced enzyme activity confers resistance to malaria.15
A Disorder of the Folate Cycle
In the mouse, methylene tetrahydrofolate deficiency confers
resistance to malaria16 and of course there is a common allele
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that reduces MTHFR activity in man, the C677T allele. Again
resistance to malaria is suggested to be the selective advantage
conferred by the C677T allele.
Evidence of Altered B6 and/or Folate
Metabolism in Malaria
If we look at the metabolic profile of patients acutely infected
with Plasmodium falciparum, one striking feature is hyperho-
mocysteinemia.17 This suggests that the patient is trying to
reduce the operation of the folate and remethylation cycles to
impair 1-carbon metabolism in the parasite. This may indicate
reduced availability of 1 of the 4 vitamins involved in the
folate cycle.
Nutritional Immunity Affecting Other
Micronutrients in Malaria
If we believe that the human host has improved the efficiency
of its nutritional immunity during evolution where malaria
acted as a selective pressure, we might expect evidence of
upregulation of genes involved in micronutrient metabolism
or transport during infection. Idaghdour and co-workers
looked at whole-blood transcriptomes of Plasmodium falci-
parum-infected West African children.18 Among the genes
upregulated in the white cells of infected children were 2
genes affecting trace metal metabolism:
SLC39A8 is a transporter of manganese and zinc. It is
known to be upregulated as a result of T-cell activation, espe-
cially at low zinc concentrations, and it is tempting to suggest
that increased cellular uptake of zinc and/or manganese is play-
ing a role in combating the infection with the parasite.
SCO1 is a copper chaperone, known to us because of its
involvement in complex IV assembly. It is tempting to suggest
that overexpression in response to Plasmodium infection
exposes the parasite to either copper deficiency or copper
toxicity.
Other Infections in Inborn Errors
of Micronutrient Metabolism
We have tried to convince you that there is an important link
between micronutrient metabolism and infection. If this is the
case, we should see altered susceptibility to infection in our
patients with inborn errors of micronutrient metabolism.
There is good evidence for this in hereditary hemochroma-
tosis. Several papers have drawn attention to infections that
appear to be more serious or more common in patients with
hemochromatosis including those caused by Listeria, Mucor,
and Aspergillus species.19
On the other hand, the Hfe knockout mouse is resistant to
infection with the Salmonella that causes a typhoid fever-like
illness in the mouse, Salmonella typhimurium. This has been
attributed to impaired ability of the knockout mouse to restrict
the parasite’s access to intracellular iron.20
Conclusions
We hope we have convinced you that many micronutrients are
reactive chemicals that the body handles with care, for exam-
ple, through the use of binding proteins. Through evolution, we
have learned to use micronutrients in the fight against infection.
Ideally every individual (whether asymptomatic or with
symptoms resulting from grossly deranged metabolism)
should have a diet to suit their genome—“nutrigenomics.”
However, the dietary “prescription” needs to take account
of geographical features; micronutrient availabilities differ
in different parts of the world. The diet also needs to encour-
age the most beneficial gut flora. It may need to be modified
to improve resistance to prevalent infections. Over long peri-
ods of time, evolution makes appropriate genomic adjust-
ments to suit micronutrient availability and prevalent
infections. An IEM can affect the individual’s ability to use
“nutritional immunity” to fight infection, for example, heredi-
tary hemochromatosis confers resistance to some infections
but susceptibility to others.
Authors’ Note
All work done in our laboratory was performed with ethical approval.
Specific approval details can be found in References 4, 8, 13 and 14.
Declaration of Conflicting Interests
The author(s) declared no potential conflicts of interest with respect to
the research, authorship, and/or publication of this article.
Funding
The author(s) received no financial support for the research, author-
ship, and/or publication of this article.
ORCID iD
Peter T. Clayton, MD http://orcid.org/0000-0001-7592-4302
References
1. Clayton PT. B6-responsive disorders: a model of vitamin depen-
dency. J Inherit Metab Dis. 2006;29(2-3):317-326.
2. Farrant RD, Walker V, Mills GA, Mellor JM, Langley GJ. Pyr-
idoxal phosphate de-activation by pyrroline-5-carboxylic acid.
Increased risk of vitamin B6 deficiency and seizures in hyperpro-
linemia type II. J Biol Chem. 2001;276(18):15107-15116.
3. Mills PB, Struys E, Jakobs C, et al. Mutations in antiquitin in
individuals with pyridoxine-dependent seizures. Nat Med. 2006;
12(3):307-309.
4. Darin N, Reid E, Prunetti L, et al. Mutations in PROSC disrupt
cellular pyridoxal phosphate homeostasis and cause vitamin-
B(6)-dependent epilepsy. Am J Hum Genet. 2016;99(6):
1325-1337.
5. Plecko B, Zweier M, Begemann A, et al. Confirmation of muta-
tions in PROSC as a novel cause of vitamin B (6)-dependent
epilepsy. J Med Genet. 2017;54(12):809-814.
6. WHO/WFP/UNICEF Statement. http://www.who.int/nutrition/
publications/micronutrients/WHO_WFP_UNICEFstatement.
pdf?ua¼1. Accessed October 2017.
4 Journal of Inborn Errors of Metabolism & Screening
7. White L, Romagne´ F, Mu¨ller E, et al. Genetic adaptation to levels
of dietary selenium in recent human history.Mol Biol Evol. 2015;
32(6):1507-1518.
8. Scott TA, Quintaneiro LM, Norvaisas P, et al. Host-microbe co-
metabolism dictates cancer drug efficacy in C. elegans. Cell.
2017;169(3):442-456.
9. Jin D, Wu S, Zhang YG, Lu R, et al. Lack of vitamin D receptor
causes dysbiosis and changes the functions of the murine intest-
inal microbiome. Clin Ther. 2015;37(5):996-1009.
10. Flanagan JM, Beutler E. The genetic basis of human erythrocyte
pyridoxal kinase activity variation. Haematologica. 2006;91(6):
801-804.
11. Kark JA, Bongiovanni R, Hicks CU, Tarassoff PG, Hannah JS,
Yoshida GY. Modification of intracellular hemoglobin with pyr-
idoxal and pyridoxal 5’-phosphate. Blood Cells. 1982;8(2):
299-314.
12. Aidoo M, Terlouw DJ, Kolczak MS, et al. Protective effects of the
sickle cell gene against malaria morbidity and mortality. Lancet.
2002;359(9314):1311-1312.
13. Wilson MP, Footitt EJ, Papandreou A, et al. An LC-MS/MS-
based method for the quantification of Pyridox(am)ine 5’-Phos-
phate Oxidase activity in dried blood spots from patients with
epilepsy. Anal Chem. 2017;89(17):8892-8900.
14. Mills PB, Camuzeaux SS, Footitt EJ, et al. Epilepsy due to
PNPO mutations: genotype, environment and treatment
affect presentation and outcome. Brain. 2014;137(Pt 5):
1350-1360.
15. Anderson BB, Giuberti M, Perry GM, Salsini G, Casadio I, Vullo
C. Low red blood cell glutathione reductase and pyridoxine phos-
phate oxidase activities not related to dietary riboflavin: selection
by malaria? Am J Clin Nutr. 1993;57(5):666-672.
16. Meadows DN, Pyzik M, Wu Q, et al. Increased resistance to
malaria in mice with methylenetetrahydrofolate reductase
(Mthfr) deficiency suggests a mechanism for selection of the
MTHFR 677C>T (c.665C>T) variant. Hum Mutat. 2014;35(5):
594-600.
17. Chillemi R, Zappacosta B, Simpore` J, Persichilli S, Musumeci M,
Musumeci S. Hyperhomocysteinemia in acute Plasmodium falci-
parum malaria: an effect of host–parasite interaction. Clin Chim
Acta. 2004;348(1-2):113-120.
18. Idaghdour Y, Quinlan J, Goulet JP, et al. Evidence for additive
and interaction effects of host genotype and infection in malaria.
Proc Natl Acad Sci U S A. 2012;109(42):16786-16793.
19. Khan FA, Fisher MA, Khakoo RA. Association of hemochroma-
tosis with infectious diseases: expanding spectrum. Int J Infect
Dis. 2007;11(6):482-487.
20. Nairz M, Theurl I, Schroll A, et al. Absence of functional Hfe
protects mice from invasive Salmonella enterica serovar Typhi-
murium infection via induction of lipocalin-2. Blood. 2009;
114(17):3642-3651.
Clayton and Mills 5
